BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3132352)

  • 21. A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation.
    Tirlapur VG; Mir MA
    Postgrad Med J; 1983; 59 Suppl 2():30-4. PubMed ID: 6136959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained antianginal efficacy of oral high-dose isosorbide dinitrate in patients with coronary heart disease.
    Schneider W; Wietschoreck A; Bussmann WD; Kaltenbach M
    Z Kardiol; 1983; 72 Suppl 3():259-67. PubMed ID: 6666231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M; Sadowski Z
    Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of angina pectoris patients with niludipine a new calcium antagonistic drug.
    Maeda K; Tanaka C; Yagi Y; Fujita K; Oshiro T; Itsumi H; Furukawa K; Imako K; Kurata N; Tsukano Y; Shiota K
    Arzneimittelforschung; 1981; 31(5):830-4. PubMed ID: 6791665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of diuretics on the magnitude of the effect of isosorbide dinitrate given as a single dose and after long-term administration. Ergometric study in patients with stable angina pectoris].
    Rotrekl P; Vlasínová J; Manousek J; Bocek O; Vlasicová Y; Janousek S; Semrád B
    Vnitr Lek; 1994 Nov; 40(11):693-7. PubMed ID: 7810090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical effects of isosorbide dinitrate in the transdermal spray (TD Spray Iso Mack) form].
    Vítovec J; Stejfa M; Blaha M; Nĕmcová H; Roubalík P; Spác J
    Vnitr Lek; 1989 Aug; 35(8):758-64. PubMed ID: 2800383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antianginal efficacy and tolerability of 50 mg sustained-release isosorbide 5-mononitrate in an open twelve-month observation study.
    Heepe W; Gathmann-Lewik U
    Cardiology; 1987; 74 Suppl 1():34-9. PubMed ID: 3111689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of perhexiline maleate in patients with angina pectoris.
    Burns-Cox CJ; Chandrasekhar KP; Ikram H; Peirce TH; Pilcher J; Quinlan CD; Rees JR
    Br Med J; 1971 Dec; 4(5787):586-8. PubMed ID: 5002115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methodological aspects of clinical evaluation of antianginal drugs.
    Jasiński K; Wierzchowiecki M; Poprawski K
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):368-71. PubMed ID: 357310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of various schedules of administration of propranolol to patients with stenocardia (a cooperative study)].
    Kardiologiia; 1989 Feb; 29(2):38-42. PubMed ID: 2498565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relation of the anti-anginal effect of nitroglycerin and its blood level in patients with stable exertion-induced stenocardia].
    Metelitsa VI; Martsevich SIu; Blagodatskikh SV; Piotrovskiĭ VK; Riabokon' OS
    Kardiologiia; 1988 Oct; 28(10):10-4. PubMed ID: 3147338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placebo effect in the treatment of angina pectoris.
    Folli G; Radice M; Beltrami A; Potenza S; Mariotti G
    Acta Cardiol; 1978; 33(4):231-9. PubMed ID: 309264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilot trial to determine the efficacy of a low dose of fish oil in the treatment of angina pectoris in the geriatric patient.
    Aucamp AK; Schoeman HS; Coetzee JH
    Prostaglandins Leukot Essent Fatty Acids; 1993 Sep; 49(3):687-9. PubMed ID: 8248274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The clinical efficacy of plasmosorption in stenocardia].
    Fomichev AN; Fedoseev AN; Narynskiĭ AA
    Klin Med (Mosk); 1992; 70(11-12):30-2. PubMed ID: 1294817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time course of long-term placebo therapy effects in angina pectoris.
    Boissel JP; Philippon AM; Gauthier E; Schbath J; Destors JM
    Eur Heart J; 1986 Dec; 7(12):1030-6. PubMed ID: 3104043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacodynamics and results of a clinical trial of nitrogranulong, a new Soviet long-acting preparation of nitroglycerin].
    Sokolov SIa; Belova LF; Trumpe TE; Alibekov SD; Sakovich GS; Rusakova KA; Ivanov AA; Belozerova OP
    Kardiologiia; 1990 Oct; 30(10):46-9. PubMed ID: 2127062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time sequence of anginal pain.
    Mattioli G; Cioni G; Andreoli C
    Clin Cardiol; 1986 Apr; 9(4):165-9. PubMed ID: 3720045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Instability of nitroglycerin tablets.
    Mayer GA
    Can Med Assoc J; 1974 Apr; 110(7):788-9 passim. PubMed ID: 4207612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of the preparation Iso Mack Retard 60 mg I 120 mg in the treatment of patients with advanced ischemic heart disease].
    Markiewicz M; Jach A; Wysokiński A
    Wiad Lek; 1992 Nov; 45(21-22):803-5. PubMed ID: 1299035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.